- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy high growth potential
Canadian Pharmaceuticals & Biotech Healthy high growth potential
Results
2
0 new
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
2 companies
Medexus Pharmaceuticals
Market Cap: CA$142.2m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$5.10
7D
25.9%
1Y
60.9%
Cardiol Therapeutics
Market Cap: CA$171.8m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.49
7D
-0.7%
1Y
-19.5%